logo
Plus   Neg
Share
Email

Starboard Urges Shareholders To Vote Against Bristol-Myers - Celgene Deal

Starboard Value LP , a shareholder of Bristol-Myers Squibb Co. (BMY), said that it has mailed a letter to Bristol-Myers shareholders regarding the Company's proposed merger with Celgene Corp. (CELG), which it believes is ill-advised and not in the best interests of Bristol-Myers shareholders. Starboard urged all shareholders to vote against the Proposed Transaction.

Starboard said it asked shareholders not to allow Bristol-Myers to bet the company on a highly-risky and likely value-destructive acquisition.

Starboard believes Bristol-Myers standalone is a safe investment with a reliable dividend; asked shareholders to not allow Bristol-Myers to incur substantial debt to buy Celgene's risky pipeline.

In January 2019, Bristol-Myers Squibb said it would acquire Celgene in a cash and stock transaction with an equity value of approximately $74 billion.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Alibaba is upgrading its intellectual property system using blockchain technology, according to local news outlet Sohu. Alibaba Platform Management expects this to benefit mainly small and medium-sized enterprises, brands and entrepreneurs. The technology will be fully implemented in September, and thereafter, the company intends to expand it to the field of digital copyright protection. Electronics retailer Best Buy Co., Inc. (BBY) reported Thursday a 27 percent increase in profit for the first quarter from last year, which was impacted by restructuring charges, and higher revenues. Both adjusted earnings per share and revenues for the quarter topped analysts' estimates. The company also provides guidance for the second quarter and reiterated its outlook for the full-year 2020. While reporting financial results for the second quarter on Thursday, Hormel Foods Corp. (HRL) lowered its earnings and net sales guidance for the full-year 2019. For fiscal 2019, the company now projects earnings in a range of $1.71 to $1.85 per share, and net sales between $9.70 billion and $10.20...
Follow RTT